1. Dabhi B, Mistry KN. In silico analysis of single nucleotide polymorphism (SNP) in human TNF-α gene. Meta gene 2014;2:586-95. doi: 10.1016/j. mgene.2014.07.005

2. Yadav AK, Tomar S, Jha AK, Singh J. Importance of molecular markers in livestock improvement: a review. Int J Agriculture Innov Res 2017;5:614-22.

3. Al-Samarai FR, Al-Kazaz AA. Molecular markers: An introduction and applications. Euro J molecul biotech 2015;9:118-30. doi: 10.13187/ ejmb.2015.9.118

4. Vignal A, Milan D, SanCristobal M, Eggen A. A review on SNP and other types of molecular markers and their use in animal genetics. Genet Sel Evol 2002;34:275-305. doi: 10.1051/gse: 002009

5. Mazrouei B, Heidari MM, Khatami M, Tahmasebi M. Molecular Mechanisms of Recurrent Pregnancy Loss. J Shahid Sadoughi Uni Med Sci 2020;28:2255-71. doi: 10.18502/ssu.v28i1.3129

6. Heidari MM, Sheikholeslami M, Yavari M, Khatami M, Seyedhassani SM. The association of renin–angiotensinogen system genes polymorphisms and idiopathic recurrent pregnancy loss. Hum Fertil 2019;22:164-70. doi: 10.1080/14647273.2017.1388545

7. Parveen F, Faridi R, Singh B, Agrawal S. Analysis of CCR5 and CX3CR1 gene polymorphisms in association with unexplained recurrent miscarriages among north Indian women. Cytokine 2011;56:239-44. doi: 10.1016/ j.cyto.2011.07.009

8. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006;6:584-94 doi: 10.1038/nri1897

9. Sonmez O, Sonmez M. Role of platelets in immune system and inflammation. Porto Biomed J 2017;2:311-14. doi: 10.1016/j.pbj.2017.05.005

10. Drake PM, Gunn MD, Charo IF, Tsou C-L, Zhou Y, Huang L, et al. Human placental cytotrophoblasts attract monocytes and CD56 bright natural killer cells via the actions of monocyte inflammatory protein 1α. J Exp Med 2001;193:1199-212. doi: 10.1084/jem.193. 10.1199

11. Red-Horse K, Drake PM, Fisher SJ. Human pregnancy: the role of chemokine networks at the fetal-maternal interface. J Exp Med 2004;6:1. doi: 10.1017/S1462399404007720

12. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX 3 C motif. Nature. 1997;385:640-4. doi: 10.1038/385640a0

13. Hannan NJ, Jones RL, Critchley HO, Kovacs GJ, Rogers PA, Affandi B, et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. J Clin Endocrinol Metab 2004;89:6119-29. doi: 10.1210/jc.2003-031379

14. Huang S, Zhao P, Yang L, Chen Y, Yan J, Duan E, et al. Fractalkine is expressed in the human ovary and increases progesterone biosynthesis in human luteinised granulosa cells. Reprod Biol Endocrinol 2011;9:95. doi: 10.1186/1477-7827- 5

15. Stepanian A, Benchenni S, Beillat-Lucas T, Omnes S, Defay F, Peynaud-Debayle E, et al. Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study. PLoS One 2009;4:e6192. doi: 10.1371/journal.pone.0006192

16. Kervancioglu Demirci E, Salamonsen LA, Gauster M. The role of CX3CL1 in fetal-maternal interaction during human gestation. Cell Adh Migr 2016;10:189-96. doi: 10.1080/19336918. 2015.1089378

17. Cardona SM, Kim SV, Church KA, Torres VO, Cleary IA, Mendiola AS, et al. Role of the fractalkine receptor in CNS autoimmune inflammation: new approach utilizing a mouse model expressing the human CX3CR1I249/M280 variant. Front Cell Neurosci 2018;12:365. doi: 10.3389/fncel.2018.00365

18. Mwapagha L, Ng’ang’a Z, Mutuiri S, Miheso B, Khamadi S. Genetic Polymorphisms of the CX3CR1 Gene Associated with HIV-1 Infections in Kenyan Population. J AIDS Clin Res. 2017;8:2. doi: 10.4172/2155-6113.1000712

19. Moatti D, Faure S, Fumeron F, Amara MEW, Seknadji P, McDermott DH, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001;97:1925-8. doi: 10.1182/blood.V97.7.1925

20. Wojdasiewicz P, Poniatowski ŁA, Kotela A, Deszczyński J, Kotela I, Szukiewicz D. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis. Arch Immunol Ther Exp 2014;62:395-403. doi: 10.1007/s00005-014-0275-0

21. Poniatowski ŁA, Wojdasiewicz P, Krawczyk M, Szukiewicz D, Gasik R, Kubaszewski Ł, et al. Analysis of the role of CX3CL1 (Fractalkine) and its receptor CX3CR1 in traumatic brain and spinal cord injury: Insight into recent advances in actions of neurochemokine agents. Mol Neurobiol 2017;54:2167-88. doi: 10.1007/s12035-016-9787-4

22. Shimoya K, Zhang Q, Tenma K, Ota Y, Hashimoto K, Shizusawa Y, et al. Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy. Mol Hum Reprod 2003;9:97-101. doi: 10.1093/molehr/gag009

23. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521-30. doi: 10.1016/S0092-8674(00)80438-9

24. Aguiar TFM, Rivas MP, Costa S, Rodrigues T, de Barros JS, Barbosa AC, et al. Mutational burden of hepatoblastomas: a role for the CX3CL1/ CX3CR1 chemokine signaling pathway. bioRxiv 2019:555466. doi: 10.1101/555466

25. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003;58:69-77. doi: 10.1016/S0165-0378(02) 00059-1

26. Furio E, García-Fuster MJ, Redon J, Marques P, Ortega R, Sanz MJ, et al. CX3CR1/CX3CL1 Axis Mediates Platelet–Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis. Thromb Haemost 2018;118:562-71. doi: 10.1055/s-0038-1629897